探索辅酶Q10对女性生育能力的保护作用
Yu Jiang1,2, Yao Han1,2, Pengyun Qiao1,2
1Department of Reproductive Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong, China.
Frontiers in cell and developmental biology
|September 15, 2025
概括
辅酶Q10 (CoQ10) 补充剂通过提高卵细胞质量和卵巢功能来改善女性生育能力和辅助生殖技术 (ART) 的成功. 它为不孕症提供了一个有前途的治疗策略,特别是在老年妇女或卵巢储量减少的妇女中.
科学领域:
- 生殖医学 生殖医学
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- 全球生育率正在下降,人们越来越依赖辅助生殖技术 (ART).
- 抗氧化剂补充剂,特别是辅酶Q10 (CoQ10),正在探索改善生育能力和ART结果.
- 辅酶Q10是一种重要的脂溶性诺基,参与线粒体能量代谢和抗氧化剂防御.
研究的目的:
- 审查辅酶Q10保护女性生育能力的机制.
- 综合有关CoQ10对卵细胞质量,卵巢功能和ART成功的影响的证据.
- 探索CoQ10在管理诸如早产卵巢衰竭和多囊性卵巢综合征等疾病方面的潜力.
主要方法:
- 文献综述综合了关于辅酶Q10和女性生育能力的当前证据.
- 对CoQ10在线粒体功能和氧化应激调节中的生化作用的分析.
- 对辅酶Q10补充和ART结果的临床研究数据的检查.
主要成果:
- 辅酶Q10调节氧化应激,减少活性氧物种 (ROS),提高卵细胞质量和线粒体效率.
- 临床研究表明,辅酶Q10补充可以改善卵巢功能,卵子产量和胚胎质量,特别是在老年妇女或卵巢储备减少的妇女身上.
- 辅酶Q10对卵细胞成熟,胚胎发育和卵巢衰老具有保护作用.
结论:
- 辅酶Q10是增强女性生育能力和ART成功的有前途的治疗剂.
- 它的抗氧化和增强线粒体的特性为生殖健康提供了显著的好处.
- 对于 CoQ10 在生殖医学中的进一步临床应用指南是有必要的.
相关概念视频
Infertility in Females
3.7K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
3.7K
Infertility in Males
528
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
528
Teratogenicity
4.0K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Cofactors and Coenzymes
87.0K
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.
87.0K
Cofactors and Coenzymes
12.6K
Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
12.6K
Hormonal Regulation of the Menstrual Cycle
1.5K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.5K


